Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Quickly remove the needle without changing the angle
General Dosage: 1.6 to 1.9 kilos inject 0.3 cc IM 2.0 to 2.3 kilos inject 0.4 cc IM
Your provider sets the schedule for you
Retatrutide is an investigational triple-agonist that is not currently FDA-approved for clinical weight-loss use
Diabetes medications may need clinician review if glucose levels change with reduced intake
What Are the Potential Benefits Researchers Study With DSIP
US$ 27.50
US$ 20.64
US$ 20.04
